Thursday, March 16, 2023: Payers

As the public health emergency ends, Medicaid enrollees and the health insurance companies that cover them face major disruptions in the coming months as states resume removing people who no longer qualify for the program. A Modern Healthcare article states that an...

Thursday, March 16, 2023: D.C. News

A new staff report from the Food and Drug Administration (FDA) says that Pfizer’s antiviral COVID-19 treatment, Paxlovid, is safe and effective at treating adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, including...